Next Article in Journal
Short-Term Periodic Fasting Reduces Ischemia-Induced Necrosis in Musculocutaneous Flap Tissue
Next Article in Special Issue
Ruscogenin Attenuates Ulcerative Colitis in Mice by Inhibiting Caspase-1-Dependent Pyroptosis via the TLR4/NF-κB Signaling Pathway
Previous Article in Journal
Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy
Previous Article in Special Issue
Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 12
Issue 3
10.3390/biomedicines12030689
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches †

by
Dingpei Long
1,2
1
State Key Laboratory of Resource Insects, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400715, China
2
Institute for Biomedical Sciences, Center for Inflammation, Immunity & Infection, Digestive Disease Research Group, Georgia State University, Atlanta, GA 30303, USA
†
This article belongs to the Special Issue Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches.
Biomedicines 2024, 12(3), 689; https://doi.org/10.3390/biomedicines12030689
Submission received: 27 February 2024 / Accepted: 17 March 2024 / Published: 19 March 2024
(This article belongs to the Special Issue Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Inflammatory bowel disease (IBD) is a non-specific autoimmune condition impacting the gastrointestinal tract, encompassing Crohn’s disease (CD) and ulcerative colitis (UC) [...]

Share and Cite

MDPI and ACS Style

Long, D. Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2024, 12, 689. https://doi.org/10.3390/biomedicines12030689

AMA Style

Long D. Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines. 2024; 12(3):689. https://doi.org/10.3390/biomedicines12030689

Chicago/Turabian Style

Long, Dingpei. 2024. "Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches" Biomedicines 12, no. 3: 689. https://doi.org/10.3390/biomedicines12030689

APA Style

Long, D. (2024). Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 12(3), 689. https://doi.org/10.3390/biomedicines12030689

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop